Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (491-500 of 532) with videos related to

Pageof 54
Sort By:
British Journal of Cancer|June 1, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusionsNicola C Venn, Libby Huang, Lenka Hovorková, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site GroupK I Pritchard, A H Paterson, S Fine, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Nature Communications|September 3, 2024
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cellsRachid Safi, Suzanne E Wardell, Paige Watkinson, et al.
Journal of Medicinal Chemistry|March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast CancerGeorge S Tria, Tinya Abrams, Jason Baird, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Oncogene|August 22, 2012
Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiationM Calao, E O Sekyere, H J Cui, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Pageof 54

Showing results (491-500 of 532) with videos related to

Sort By:
Pageof 54
British Journal of Cancer|June 1, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusionsNicola C Venn, Libby Huang, Lenka Hovorková, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site GroupK I Pritchard, A H Paterson, S Fine, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Nature Communications|September 3, 2024
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cellsRachid Safi, Suzanne E Wardell, Paige Watkinson, et al.
Journal of Medicinal Chemistry|March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast CancerGeorge S Tria, Tinya Abrams, Jason Baird, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Oncogene|August 22, 2012
Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiationM Calao, E O Sekyere, H J Cui, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Pageof 54